myClin is a leading Software as a Service (SaaS) platform specializing in Clinical Trial Compliance and Oversight. The platform enables secure document exchange between sites, sponsors, and CROs, tracks study communications, centralizes study training, and provides unique Compliance Scoring insights.
The hallmark feature of myClin is the Compliance Score, which allows stakeholders to identify and measure hidden study compliance gaps. It offers a clear and objective metric to enhance readership of essential study documents, delivery of critical study updates, and training.
Established in 2008, myClin's mission has been to leverage technology for improved oversight, compliance, engagement, and collaboration in clinical trials. With a team of clinical research veterans, the platform has been utilized in global bio-pharmaceutical and device studies, boasting thousands of clinical users.
Operating within the Information Technology industry, myClin is headquartered in the United States.
Although specific details on the last investment and investors are not available at this time, myClin's focus on leveraging technology to enhance clinical trial operations positions it as an intriguing prospect for potential investors looking to participate in the evolving landscape of healthcare technology.
There is no investment information
No recent news or press coverage available for myClin.